BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 23684824)

  • 1. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.
    Davis SM; Deloria-Knoll M; Kassa HT; O'Brien KL
    Vaccine; 2013 Dec; 32(1):133-45. PubMed ID: 23684824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.
    Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC
    Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
    Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
    Hum Vaccin Immunother; 2016; 12(2):268-76. PubMed ID: 26430921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imputing the Direct and Indirect Effectiveness of Childhood Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease by Surveying Temporal Changes in Nasopharyngeal Pneumococcal Colonization.
    Nzenze SA; Madhi SA; Shiri T; Klugman KP; de Gouveia L; Moore DP; Karstaedt AS; Tempia S; Nunes MC; von Gottberg A
    Am J Epidemiol; 2017 Aug; 186(4):435-444. PubMed ID: 28482004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.
    Cheung YB; Zaman SM; Nsekpong ED; Van Beneden CA; Adegbola RA; Greenwood B; Cutts FT
    Pediatr Infect Dis J; 2009 Nov; 28(11):990-5. PubMed ID: 19536041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rise and fall of pneumococcal serotypes carried in the PCV era.
    Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
    Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
    Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine.
    Kuo CY; Hwang KP; Hsieh YC; Cheng CH; Huang FL; Shen YH; Huang YC; Chiu CH; Chen PY; Lin TY
    Vaccine; 2011 Jul; 29(32):5171-7. PubMed ID: 21621578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.
    van Hoek AJ; Sheppard CL; Andrews NJ; Waight PA; Slack MP; Harrison TG; Ladhani SN; Miller E
    Vaccine; 2014 Jul; 32(34):4349-55. PubMed ID: 24657717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation.
    Dagan R
    Expert Rev Vaccines; 2019 Jun; 18(6):641-661. PubMed ID: 31230486
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
    Parra EL; De La Hoz F; Díaz PL; Sanabria O; Realpe ME; Moreno J
    Vaccine; 2013 Aug; 31(37):4033-8. PubMed ID: 23680440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the effects of pneumococcal conjugate vaccine (PCV7) on Streptococcus pneumoniae carriage and antibiotic resistance: the Palestinian-Israeli Collaborative Research (PICR).
    Daana M; Rahav G; Hamdan A; Thalji A; Jaar F; Abdeen Z; Jaber H; Goral A; Huppert A; Raz M; Regev-Yochay G;
    Vaccine; 2015 Feb; 33(8):1021-6. PubMed ID: 25593104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: Systematic review and meta-analyses of randomised controlled trials.
    Nicholls TR; Leach AJ; Morris PS
    Vaccine; 2016 Feb; 34(6):703-13. PubMed ID: 26742947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.
    Milucky J; Carvalho MG; Rouphael N; Bennett NM; Talbot HK; Harrison LH; Farley MM; Walston J; Pimenta F; Lessa FC;
    Vaccine; 2019 Feb; 37(8):1094-1100. PubMed ID: 30685247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization.
    Loo JD; Conklin L; Fleming-Dutra KE; Knoll MD; Park DE; Kirk J; Goldblatt D; O'Brien KL; Whitney CG
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S161-71. PubMed ID: 24336058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The worldwide impact of the seven-valent pneumococcal conjugate vaccine.
    Fitzwater SP; Chandran A; Santosham M; Johnson HL
    Pediatr Infect Dis J; 2012 May; 31(5):501-8. PubMed ID: 22327872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct and Indirect Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine Against Carriage in a Cluster Randomized Trial.
    Palmu AA; Toropainen M; Kaijalainen T; Siira L; Lahdenkari M; Nieminen H; Syrjänen RK; Kilpi TM; Jokinen J
    Pediatr Infect Dis J; 2017 Dec; 36(12):1193-1200. PubMed ID: 28737627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcus pneumoniae serotype 19A: worldwide epidemiology.
    Isturiz R; Sings HL; Hilton B; Arguedas A; Reinert RR; Jodar L
    Expert Rev Vaccines; 2017 Oct; 16(10):1007-1027. PubMed ID: 28783380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci.
    Devine VT; Jefferies JM; Clarke SC; Faust SN
    J Immunol Res; 2015; 2015():394368. PubMed ID: 26351646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage.
    Ojal J; Hammitt LL; Gaitho J; Scott JAG; Goldblatt D
    Vaccine; 2017 Aug; 35(35 Pt B):4652-4657. PubMed ID: 28739116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.